Chairman:  Joe Pitts (PA-16)
Public health and quarantine; hospital construction; mental health; biomedical research and development; health information technology, privacy, and cybersecurity; public health insurance (Medicare, Medicaid) and private health insurance; medical malpractice and medical malpractice insurance; the regulation of food, drugs, and cosmetics; drug abuse; the Department of Health and Human Services; the National Institutes of Health; the Centers for Disease Control; Indian Health Service; and all aspects of the above-referenced jurisdiction related to the Department of Homeland Security.



Joe Pitts (PA), Chairman
Brett Guthrie (KY), Vice Chairman
Ed Whitfield (KY)
John Shimkus (IL)
Tim Murphy (PA)
Michael C. Burgess, M.D. (TX)
Marsha Blackburn (TN)
Cathy McMorris Rodgers (WA)
Leonard Lance (NJ)
Morgan Griffith (VA)
Gus Bilirakis (FL)
Billy Long (MO)
Renee Ellmers (NC)
Larry Bucshon (IN)
Susan Brooks (IN)
Chris Collins (NY)
Joe Barton (TX)
Fred Upton (MI) (Ex Officio)


Gene Green (TX), Ranking Member
Eliot L. Engel (NY)
Lois Capps (CA)
Jan Schakowsky (IL)
G. K. Butterfield (NC)
Kathy Castor (FL)
John Sarbanes (MD)
Doris O. Matsui (CA)
Ben Ray Lujan (NM)
Kurt Schrader (OR)
Joseph P. Kennedy, III (MA)
Tony Cardenas (CA)
Frank Pallone, Jr. (NJ) (Ex Officio)

November 25, 2015 | Press Release

WASHINGTON, DC – House Energy and Commerce Committee leaders are seeking answers from the Centers for Medicare and Medicaid Services (CMS) on the agency’s plans for continued oversight of Obamacare’s CO-OPs. To date, 12 of the original 23 CO-OPs have closed, bringing the total cost to taxpayers at more than $1.23 billion.

November 24, 2015 | Letter

Excerpt: The Committee is concerned that CMS does not have a plan to ensure that the remaining CO-OPs are financially solvent. The existing 11 CO-OPs represent over $1 billion dollars in federal loans that should be paid back to the federal treasury over the next decade.

November 23, 2015 | ICYMI

Former U.S. Senate Majority Leader Dr. Bill Frist (R-TN) on Monday weighed in on the fight against antibiotic resistant bacteria, making the case for a Limited-Population Antibacterial Drug pathway. In a column published by The Tennessean, Dr.

November 20, 2015 | ICYMI

H.R. 6 “puts the view of the patient in the center of drug discovery, development, and delivery, balanced by insights derived from data analytics, clinical science, and a more flexible approval process.”

November 19, 2015 | Press Release

WASHINGTON, DC – Continuing its work on flu preparedness, the Subcommittee on Oversight and Investigations, chaired by Rep. Tim Murphy (R-PA), today held a hearing entitled, “U.S.

November 19, 2015 | ICYMI

Upton: “UnitedHealth Group is a very large piece of the Obamacare Jenga tower…”